The field of cardiac electrophysiology has been on the cutting edge of advanced digital technologies for many years. More recently, medical device development through traditional clinical trials has been supplemented by direct to consumer products with advancement of wearables and health care apps. The rapid growth of innovation along with the mega-data generated has created challenges and opportunities. This review summarizes the regulatory landscape, applications to clinical practice, opportunities for virtual clinical trials, the use of artificial intelligence to streamline and interpret data, and integration into the electronic medical records and medical practice. Preparation of the new generation of physicians, guidance and promotion by professional societies, and advancement of research in the interpretation and application of big data and the impact of digital technologies on health outcomes will help to advance the adoption and the future of digital health care.
Bibliographical noteFunding Information:
Dr Tarakji participated in consulting/advisory Board at AliveCor, Medtronic, Boston Scientific. Dr Silva took ownership/consulting at SentiAR and participated in advisory Board at Cardialen. He provided grant(s) at AliveCor, SentiAR, National Institutes of Health. He provided research support at Abbott, AliveCor and royalties at UpToDate. Dr Chen received support from National Heart, Lung, and Blood Institute (NHLBI): R01 HL12663 and R01HL141288 and additional support from R01HL142599 and R01HL127659. Dr Turakhia participated in consulting/advisory board at Medtronic, Abbott, Myokardia, Pfizer, Novartis, Johnson & Johnson; received grants from American Heart Association, Bristol Myers Squibb, Apple. Dr Passman participated in consulting/advisory board at Medtronic, Abbott, Johnson and Johnson. He received grants from American Heart Association, Bristol Myers Squibb, Pfizer, and royalties from UpToDate. Dr Perez received grant funding from National Institutes of Health/NHLBI 1R01HL136390-01; Apple, Inc Consulting: Apple, Inc, Boehringer Ingelheim, Alta-Thera. Z.I. Attia provided licensed technology to AliveCor, Myant, and Eko Devices. Dr Majmudar participated consulting/advisory board at Biofourmis, Cardiogram, and HealthTensor. The other authors report no conflicts.
© 2020 American Heart Association, Inc.
- atrial fibrillation
- big data
- cardiovascular diseases